Measuring Patient Quality of Life Following Treatment for Alopecia

Figures & data

Table 1 Characteristics of Some Hair-Specific Health-Related Quality of Life Instruments Discussed in This Article

Instrument	Publication Year	Country of Origin	Language	Intended Patient Group	Recall Period	Number of Items	Scales for Items	Domains	Reliability
MHGQ	1998	USA	English	AGA in men	Since the start of treatment	17	4- to 7-point	Single	NR
WAA-QOL	2000	USA	English	AGA in women	1 week	16	7-point	Single	Cronbach’s α 0.98, ICC 0.89
Hairdex	2001	Germany	German	AGA and diffuse alopecia	NR	48	5-point	5 (emotions, functioning, symptoms, self-confidence, stigmatization)	Cronbach’s α 0.55–0.82 for each domain
WHGQ	2009	USA	English	AGA/FPHL in women	Since the start of treatment	4	NR	Single	Cronbach’s α 0.81, ICC 0.89
AAQ	2012	Japan	Japanese	AA	1 month	7	5-point	3 (restriction of activity, concealment, adaptation)	Cronbach’s α 0.59–0.81 for each domain
Hair-Specific Skindex-29	2012	Spain	Spanish	FPHL in women	NR	29	5-point	3 (emotions, functioning, symptoms)	Cronbach’s α 0.96, ICC 0.98
AASIS	2013	USA	English	AA	1 week	13	11-point	3 (interference, hair loss, other symptoms)	Cronbach’s α 0.77–0.93 for each domain
AA-QLI	2013	Italy	Italian	AA	1 month	21	4-point	3 (subjective symptoms, objective signs, relationship)	NR
A-QLI	2016	South Africa	English	Alopecia	NR	19	4-point	3 (subjective symptoms, objective signs, relationship)	NR

Abbreviations: AA, alopecia areata; AAQ, Alopecia Areata Quality of Life; AA-QLI, Alopecia Areata Quality of Life Index; AASIS, Alopecia Areata Symptom Impact Scale; AGA, androgenetic alopecia; A-QLI, Alopecia Quality of Life Indicators; FPHL, female pattern hair loss; ICC, intraclass correlation coefficient; MHGQ, Men’s Hair Growth Questionnaire; NR, not reported; WAA-QOL, Women’s Androgenetic Alopecia Quality of Life Questionnaire; WHGQ, Women’s Hair Growth Questionnaire.